Cogent Biosciences, Inc.
COGT
$34.29
-$0.24-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.00% | 66.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.13% | 19.36% | |||
| Operating Income | -4.13% | -19.36% | |||
| Income Before Tax | 5.02% | -26.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.02% | -26.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.02% | -26.64% | |||
| EBIT | -4.13% | -19.36% | |||
| EBITDA | -4.16% | -19.53% | |||
| EPS Basic | 12.14% | -16.14% | |||
| Normalized Basic EPS | 4.60% | -6.97% | |||
| EPS Diluted | 12.14% | -16.14% | |||
| Normalized Diluted EPS | 4.60% | -6.97% | |||
| Average Basic Shares Outstanding | 8.12% | 9.05% | |||
| Average Diluted Shares Outstanding | 8.12% | 9.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||